The Division of Pediatrics and Maternal Health (DPMH) oversees quality initiatives which promote and necessitate the study of drug and biological products in the pediatrics, pregnant women, and breastfeeding populations and improve pregnancy and lactation-related information in product labeling.
What is DPMH’s Role?
To collaborate to develop clinically relevant, evidence-based labeling and other communications that facilitate informed use of drugs and biologics in children, pregnant females, lactating females, and females and males of reproductive potential.
Division Director: Lynne Yao, M.D.
Deputy Director: John Alexander, M.D., MPH
Chief of Project Management Staff: Rosemary Addy
Food and Drug Administration
Center for Drug Evaluation and Research
Office of New Drugs
Division of Pediatric and Maternal Health
10903 New Hampshire Avenue
Silver Spring, MD 20993
Main Line: 301-796-2200
Resources For You
- Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine
- Office of New Drugs
- CDER Offices and Divisions
- Reorganization of the Office of New Drugs with Corresponding Changes to the Office of Translational Sciences and the Office of Pharmaceutical Quality